410 related articles for article (PubMed ID: 27618916)
1. Zhengtian Capsule versus flunarizine in patients with migraine: a multi-center, double-blind, double-dummy, randomized controlled, non-inferior clinical trial.
Cao K; Han F; Lin A; Yang W; Zhao J; Zhang H; Ding Y; Xie W; Xu Y; Yu T; Wang X; Yang X; Zhou J; Hou Q; Yu L; Gao Y
BMC Complement Altern Med; 2016 Sep; 16(1):356. PubMed ID: 27618916
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Modified Wuzhuyu Decoction Granule ( ) for Migraine Patients with Cold and Stasis Obstructing Meridian Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial.
Liu HW; Zou YH; Cao KG; Yu LH; Zhang Y; Fu CH; Ma DY
Chin J Integr Med; 2018 Jun; 24(6):409-414. PubMed ID: 28741060
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and Safety of Toutongning Capsule in Patients with Migraine: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.
Yu S; Ran Y; Wan Q; Yang X; Chen H; Wang H; Hu X; Mao S; Yu T; Luo G; Gao X; Li X; Zhou M; Li Y
J Altern Complement Med; 2019 Dec; 25(12):1215-1224. PubMed ID: 31553228
[No Abstract] [Full Text] [Related]
4. Efficacy of acupuncture for migraine prophylaxis: a single-blinded, double-dummy, randomized controlled trial.
Wang LP; Zhang XZ; Guo J; Liu HL; Zhang Y; Liu CZ; Yi JH; Wang LP; Zhao JP; Li SS
Pain; 2011 Aug; 152(8):1864-1871. PubMed ID: 21616596
[TBL] [Abstract][Full Text] [Related]
5. Treatment of migraines with Tianshu capsule: a multi-center, double-blind, randomized, placebo-controlled clinical trial.
Yu S; Ran Y; Xiao W; Tang W; Zhao J; Chen W; Zhuang H; Ouyang C; Lin H; Liu D; Chen T; Huang H; Wang B; Hao Y; Yan Z; Zhao S; Wang Y; Ni J; Wang C; Ding W; Li G; Cao J; Tian S
BMC Complement Altern Med; 2019 Dec; 19(1):370. PubMed ID: 31842860
[TBL] [Abstract][Full Text] [Related]
6. Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability.
Sørensen PS; Larsen BH; Rasmussen MJ; Kinge E; Iversen H; Alslev T; Nøhr P; Pedersen KK; Schrøder P; Lademann A
Headache; 1991 Nov; 31(10):650-7. PubMed ID: 1769820
[TBL] [Abstract][Full Text] [Related]
7. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability in migraine prophylaxis of flunarizine in reduced doses: a comparison with propranolol 160 mg daily.
Diener HC; Matias-Guiu J; Hartung E; Pfaffenrath V; Ludin HP; Nappi G; De Beukelaar F
Cephalalgia; 2002 Apr; 22(3):209-21. PubMed ID: 12047461
[TBL] [Abstract][Full Text] [Related]
9. Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients.
Lücking CH; Oestreich W; Schmidt R; Soyka D
Cephalalgia; 1988; 8 Suppl 8():21-6. PubMed ID: 3180198
[TBL] [Abstract][Full Text] [Related]
10. Flunarizine (10 and 20 mg) i.v. versus placebo in the treatment of acute migraine attacks: a multi-centre double-blind study.
Pfaffenrath V; Oestreich W; Haase W
Cephalalgia; 1990 Apr; 10(2):77-81. PubMed ID: 2193713
[TBL] [Abstract][Full Text] [Related]
11. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial.
Mitsikostas DD; Polychronidis I
Funct Neurol; 1997; 12(5):267-76. PubMed ID: 9439944
[TBL] [Abstract][Full Text] [Related]
12. Alpha-dihydroergocryptine in the prophylaxis of migraine: a multicenter double-blind study versus flunarizine.
Bussone G; Cerbo R; Martucci N; Micieli G; Zanferrari C; Grazzi L; Fabbrini G; Cavallini A; Granella F; Ambrosoli L; Mailland F; Poli A; Manzoni G
Headache; 1999 Jun; 39(6):426-31. PubMed ID: 11279920
[TBL] [Abstract][Full Text] [Related]
13. Flunarizine i.v. in the acute treatment of the migraine attack. A double-blind placebo-controlled study.
Soyka D; Taneri Z; Oestreich W; Schmidt R
Cephalalgia; 1988; 8 Suppl 8():35-40. PubMed ID: 3180201
[TBL] [Abstract][Full Text] [Related]
14. Flunarizine versus topiramate for chronic migraine prophylaxis: a randomized trial.
Lai KL; Niddam DM; Fuh JL; Chen SP; Wang YF; Chen WT; Wu JC; Wang SJ
Acta Neurol Scand; 2017 Apr; 135(4):476-483. PubMed ID: 27306581
[TBL] [Abstract][Full Text] [Related]
15. AVP-825 breath-powered intranasal delivery system containing 22 mg sumatriptan powder vs 100 mg oral sumatriptan in the acute treatment of migraines (The COMPASS study): a comparative randomized clinical trial across multiple attacks.
Tepper SJ; Cady RK; Silberstein S; Messina J; Mahmoud RA; Djupesland PG; Shin P; Siffert J
Headache; 2015 May; 55(5):621-35. PubMed ID: 25941016
[TBL] [Abstract][Full Text] [Related]
16. Flunarizine i.v. in the acute treatment of common or classical migraine attacks--a placebo-controlled double blind trial.
Soyka D; Taneri Z; Oestreich W; Schmidt R
Headache; 1989 Jan; 29(1):21-7. PubMed ID: 2647666
[TBL] [Abstract][Full Text] [Related]
17. Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial.
Martelletti P; Barbanti P; Grazzi L; Pierangeli G; Rainero I; Geppetti P; Ambrosini A; Sarchielli P; Tassorelli C; Liebler E; de Tommaso M;
J Headache Pain; 2018 Nov; 19(1):101. PubMed ID: 30382909
[TBL] [Abstract][Full Text] [Related]
18. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial.
Bordini CA; Arruda MA; Ciciarelli MC; Speciali JG
Arq Neuropsiquiatr; 1997 Sep; 55(3B):536-41. PubMed ID: 9629401
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Nimodipine Plus Yufeng Ningxin Tablets for Patients with Frequent Migraine.
Mu H; Wang L
Pharmacology; 2018; 102(1-2):53-57. PubMed ID: 29879719
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of Safety and Efficacy of Add-on Alpha-Lipoic Acid on Migraine Prophylaxis in an Adolescent Population: A Randomized Controlled Trial.
Puliappadamb HM; Satpathy AK; Mishra BR; Maiti R; Jena M
J Clin Pharmacol; 2023 Dec; 63(12):1398-1407. PubMed ID: 37563914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
